RAC 5.59% $1.70 race oncology ltd

I speculate that RAC have a background activity working on an...

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29637
    I speculate that RAC have a background activity working on an oral formulation combining Zantrene and ASTX727 (note ASTX747 is a typo).

    https://www.asx.com.au/asxpdf/20211101/pdf/452fm1vcm8f2j0.pdf

    Screen Shot 2021-12-16 at 12.01.11 pm.png

    https://astx.com/research-developme...azuridine-astx727-hematological-malignancies/

    Otsuka have their own program developing an oral combination - from the above link:

    Screen Shot 2021-12-16 at 12.09.23 pm.png
    So I'm wondering if there will be an oral formulation combining decitabine, cedazuridine and Zantrene once data to help determine optimal dosage is generated.

    Screen Shot 2021-12-16 at 12.16.39 pm.png
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.70
Change
0.090(5.59%)
Mkt cap ! $289.5M
Open High Low Value Volume
$1.60 $1.76 $1.59 $142.7K 84.97K

Buyers (Bids)

No. Vol. Price($)
2 17175 $1.70
 

Sellers (Offers)

Price($) Vol. No.
$1.77 6060 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.